| GTO ID | GTC0996 |
| Trial ID | ChiCTR2200060553 |
| Disease | B-Cell Lymphoma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Chimeric antigen receptor T cells (CAR-T) in the treatment of refractory/relapsed B-cell lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | Shaanxi Provincial People's Hospital |
| Cohort 1 | |||||||
|
|||||||